1.
Susceptibility analysis of mutations that confer resistance to inhibitors of the SARS-CoV-2 main protease (Mpro) and RNA-dependent RNA polymerase (RdRp). ACI. 2022;29(2):102-119. doi:10.31243/aci.v29i2.1845